Group 1: Investor Relations Activities - The company participated in the 2024 North Exchange Roadshow on December 6, 2024, with media interviews and site visits conducted by the chairman and general manager [2][3]. Group 2: Product Development and Market Strategy - The company aims for full coverage in the rehabilitation medical device sector, with the biological stimulation feedback device achieving its medical device registration in September 2024 and meeting market promotion expectations [3]. - The company plans to launch new medical devices, including shortwave therapy devices and pelvic rehabilitation devices, by early 2025 [3]. - The variable amplitude fascia gun has been well-received in the global market, solidifying the company's leadership in this product category [4]. - The portable oxygen machine, weighing 1.5 kg with a 3-hour battery life, has ranked first in sales among portable oxygen machines priced over 5000 yuan during major sales events [4]. Group 3: Market Outlook and Trends - The rehabilitation technology market is experiencing continuous growth, driven by an aging population and increasing demand for rehabilitation products [5]. - The company is optimistic about the future of rehabilitation technology, emphasizing the integration of smart and personalized solutions in product development [6]. - The company recognizes the importance of cross-disciplinary technology integration to provide comprehensive rehabilitation services [6]. Group 4: Expansion and Capacity Building - The company is purchasing a factory in Dongguan to address production space issues and expand capacity, with an annual rental cost of approximately 3 million yuan for the current leased space [7]. - The new factory will enhance production efficiency, reduce costs, and improve product quality, reflecting the company's confidence in future growth [8]. Group 5: Innovation and Product Diversification - The company emphasizes innovation as a core driver of growth, with a focus on developing products that meet consumer needs, such as the variable amplitude fascia gun [9]. - Future product development will include therapeutic robots for wellness centers, integrating various treatment modalities to enhance user experience [5]. Group 6: Financial Performance and Investor Relations - The company has faced challenges in revenue growth due to market conditions but plans to counteract this by developing new products and expanding market reach [10]. - The company aims to enhance investor returns through continuous growth and a reasonable dividend policy, while also improving investor relations and communication [14]. Group 7: Mergers and Acquisitions - The company is considering mergers and acquisitions to enhance its competitive edge, focusing on firms with core technologies or strong market channels [13].
倍益康(870199) - 投资者关系活动记录表